Evidence map›Paper›PMID 28834955›Full record

ArticleThe Pediatric infectious disease journal2018

Higher Transplacental Pathogen-Specific Antibody Transfer Among Pregnant Women Randomized to Triple Antiretroviral Treatment Versus Short Course Zidovudine.

Rose Bosire, Carey Farquhar, Ruth Nduati, Kristina Broliden, Stanley Luchters, Philippe Van de Perre, Isabelle De Vincenzi, Michele Merkel, Veronicah Wachuka, Dorothy Mbori-Ngacha and 3 more

Abstract read
In one paragraph

Article in The Pediatric infectious disease journal, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 17 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Observational
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 7 countries.

Rose Bosire
Carey Farquhar
Ruth Nduati
Kristina Broliden
Stanley Luchters
Philippe Van de Perre
Isabelle De Vincenzi
Michele Merkel
Veronicah Wachuka
Dorothy Mbori-Ngacha
Grace John-Stewart
Barbara Lohman-Payne
Marie Reilly
World Health Organization · CHUniversity of Washington · USKenya Medical Research Institute · KEUniversité de Montpellier · FRInternational Centre for Reproductive Health Kenya · KEKarolinska University Hospital · SE

Funding

INTERNATIONAL TRAINING GRANT IN EPIDEMIOLOGYD43TW000007 · FIC · UNIVERSITY OF WASHINGTON · PI FARQUHAR, CAREY · 1988 to 2012
$16.3M
NPGH LEADERs YR12: OBSSR (Greenberg, Ngwafong Mukere) & NIBIB (Lee)D43TW009345 · FIC · UNIVERSITY OF WASHINGTON · PI Dibyadyuti Datta, Chandy C. John · 2017 to 2026
$15.2M
Northern/Pacific Universities Global Health Research Training ConsortiumR25TW009345 · FIC · UNIVERSITY OF WASHINGTON · PI KOLARS, JOSEPH C., NERURKAR, VIVEK RAMCHANDRA · 2012 to 2016
$5.9M
Women and HIV: Translation of Research into Practice-WLHIV Post-Graduate Research FellowshipD43TW009783 · FIC · UNIVERSITY OF WASHINGTON · PI Elizabeth Anne BUKUSI, CAREY FARQUHAR · 2015 to 2026
$4.1M
Pediatric HIV-1 in Africa: Pathogenesis and ManagementK24HD054314 · NICHD · UNIVERSITY OF WASHINGTON · PI JOHN-STEWART, GRACE C. · 2006 to 2016
$1.2M
HIV-1 and Protective Immunity against Common Childhood PathogensK24AI087399 · NIAID · UNIVERSITY OF WASHINGTON · PI FARQUHAR, CAREY · 2010 to 2014
$647k
Impact of counseling on breastfeeding practice and infant HIV-1 transmissionR01TW007629 · FIC · KENYA MEDICAL RESEARCH INSTITUTE (KEMRI) · PI BOSIRE, ROSE KERUBO OTISO · 2007 to 2011
$253k
FIC NIH HHS D43 TW000007FIC NIH HHS D43 TW009345FIC NIH HHS D43 TW009783FIC NIH HHS R01 TW007629FIC NIH HHS R25 TW009345NIAID NIH HHS K24 AI087399NICHD NIH HHS K24 HD054314World Health Organization 001
6 · The paper itself

Abstract

backgroundHIV-1 infection may impair transplacental antibody transfer to infants. The impact of highly active antiretroviral treatment (ART) given during pregnancy on transplacental antibody transport is unknown.

methodsHIV-1 infected pregnant women with CD4 counts between 200 - 500 were randomized to short-course zidovudine (ZDV) or triple ART at 32 weeks gestation for prevention of mother-to-child HIV-1 transmission. Levels of maternal antibody against measles, pneumococcus and rotavirus at delivery, and antibody transfer to the baby through cord blood, were compared between trial arms.

resultsOverall, 141 and 148 women were randomized to triple ART and ZDV, respectively; cord blood was available for a subset (n = 20 in triple ART and n = 22 in ZDV). Maternal antibody levels to all pathogens during pregnancy and at delivery were not significantly different between arms. Within each arm, antibody levels at delivery were lower than at enrolment. For all antibodies, a woman's levels before delivery were an important predictor of amount transferred to her infant. Women on triple ART transferred higher levels of pathogen-specific antibodies when compared with women on short course ZDV.

conclusionsWomen on triple ART transferred higher levels of pathogen-specific antibodies compared with women on ZDV alone.

Indexed as

Immunity, Maternally-AcquiredAdultAntiretroviral Therapy, Highly ActiveCD4 Lymphocyte CountFemaleHIV-1HIV AntibodiesHIV InfectionsHumansImmunoglobulin GKenyaMedication AdherencePregnancyPregnancy Complications, InfectiousTreatment OutcomeViral LoadHIV AntibodiesImmunoglobulin GZidovudine

Identifiers

PMID28834955
PMCPMC5807132
OpenAlexW2747049178

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.